Roche Selects Veeva Development Cloud Applications
Veeva Systems (NYSE: VEEV) today announced that Roche (SWX: ROG) has selected Veeva Development Cloud applications globally to streamline clinical, regulatory, and quality processes. The company is switching to unified applications in Vault Clinical, Vault RIM, and Vault Quality suites to increase efficiency, enhance data quality, and drive compliance throughout the product lifecycle.
Roche selects Veeva Development Cloud applications to increase efficiency, enhance data quality, and drive compliance throughout the product lifecycle.
“Speeding drug development and product supply are strategic priorities for innovative life sciences companies like Roche,” said Rik Van Mol, vice president of Veeva Development Cloud. “Veeva Development Cloud breaks down system and process silos so life sciences companies can more quickly bring innovative treatments to patients.”
Roche is standardizing on clinical applications Vault eTMF and Vault CTMS, regulatory applications Vault Submissions, Vault Registrations, and Vault Submissions Archive, and quality applications Vault QMS and Vault QualityDocs.